Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS

Lancet Oncology

Volumn 4, Issue 2, 2003, Pages 110-119

  Dal Maso, Luigino ^a   Franceschi, Silvia ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AUSTRALIA; BRAIN LYMPHOMA; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER REGISTRY; CANCER RISK; DEATH; DEVELOPED COUNTRY; EUROPE; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LEUKEMIA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; POPULATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; T CELL LYMPHOMA; UNITED STATES;

EID: 0037320637     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(03)00983-5     Document Type: Review

References (73)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS epidemic update: December 2001. Report no UNAIDS/01.74E-WHO/CDS/CSR/EDC/2001.2. Geneva: WHO, 2001.
2. Kinlen L. Immunologic factors, including AIDS. In: Schottenfeld D, Fraumeni JF (Eds). Cancer epidemiology and prevention, 2nd edn. New York: Oxford University Press, 1996: 532-45.
3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human immunodeficiency viruses and human T-cell lymphotropic viruses. IARC monographs on the evaluation of carcinogenic risks to humans, vol 67. Lyon: IARC Press, 1996.
4. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 2001; 37: 1188-201.
5. Filipovich AH, Mathuir A, Kamat D, et al. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency 1994; 5: 91-112.
6. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic Countries, 1964-1986. Int J Cancer 1995; 60: 183-89.
7. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. IARS monographs on the evaluation of carcinogenic risks to humans, vol 70. Lyon: IARC Press, 1997.
8. Franceschi S, Dal Maso L, La Vecchia C. Advance in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer 1999; 83: 481-85.
9. Tirelli U, Spina M, Gaidano G, Vaccher E, Franceschi S, Carbone A. Epidemiology, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS 2000; 14: 1675-88.
10. Grulich AE, Li Y, McDonald A, et al. Decreasing rates of HIV-associated Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of highly active anti-retroviral therapy: national linkage study. AIDS 2001; 15: 629-33.
11. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol 1996; 94: 533-43.
12. Carbone A. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol 2002; 33: 392-404.
13. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92: 1823-30.
14. Goedert JJ, Coté TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351: 1833-39.
15. Franceschi S, Dal Maso L, Arniani S, et al. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Br J Cancer 1998; 78: 966-70.
16. Grulich AE, Wan X, Law MG, et al. Risk of cancer in people with AIDS. AIDS 1999; 13: 839-43.
17. Biggar RJ, Rosenberg PS, Coté T. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Int J Cancer 1996; 68: 754-58.
18. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352: 1725-30.
19. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60.
20. Centers for Disease Control and Prevention. Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States. MMWR Morb Mortal Wkly Rep 1985; 34: 373-75.
21. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500-10.
22. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults. MMWR Morb Mortal Wkly Rep 1992; 41: 1-19.
23. ENAADS European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe. End-year report 2001, number 66. Saint-Maurice: 2002.
24. Ancelle Park RA. Expanded European AIDS case definition. Lancet 1993; 341:441.
25. Dore GJ, Li Y, McDonald A, et al, for the National HIV Surveillance Committee. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 2002; 29: 388-95.
26. Ajdacic-Gross V, Zellweger U, Wang J, et al. How complete is AIDS surveillance in Europe? An eagle eye comparison with mortality data. J Epidemiol Commun Health 2001; 55: 52-56.
27. Grulich AE, Li Y, McDonald A, et al. Rates of on non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002; 16: 1155-61.
28. Dal Maso L, Rezza G, Zambon P, et al. Non-Hodgkin lymphoma among young adults with and without AIDS in Italy. Int J Cancer 2001; 93: 430-35.
29. Coté TR, Biggar RJ, Rosenberg P, et al. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. Int J Cancer 1997; 73: 645-50.
30. Frisch M, Biggar RJ, Engels EA, Goedert JJ, for the AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285: 1736-45.
31. Biggar RJ, Engels EA, Frisch M, Goedert JJ, on behalf of the AIDS Cancer Match Registry Study Group. Risk of T-cell lymphomas in persons with AIDS. J Acquir Immune Defic Syndr 2001; 26: 371-76.
32. Gallagher B, Wang Z, Schymura MJ, et al. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001; 154: 544-56.
33. Serraino D, Pezzotti P, Dorrucci M, et al. Cancer incidence in a cohort of human immunodeficiency virus seroconverters. Cancer 1997; 79: 1004-08.
34. Sutton L, Guénel P, Tanguy M-L, et al. Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome. Br J Haematol 2001; 112: 900-08.
35. Selik RM, Rabkin, CS. Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 1998; 90: 1300-02.
36. Conti S, Masocco M, Pezzotti P, et al. Excess mortality from liver disease and other non-AIDS-related diseases among HIV-infected individuals in Italy. J Acquir Immune Defic Syndr 2002; 29: 105-07.
37. Hooper WC, Holman RC, Clarke MJ, Chorba TL. Trends in non-Hodgkin lymphoma (NHL) and HIV-associated NHL deaths in the United States. Am J Hematol 2001; 66: 159-66.
38. Li Y, Law M, McDonald A, et al. Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus. Am J Epidemiol 2002; 155: 153-58.
39. Serraino D, Franceschi S. Kaposi's sarcoma and non-Hodgkin's lymphoma in children and adolescent with AIDS. AIDS 1996; 10: 643-47.
40. Mueller BU. Cancer in children infected with the human immunodeficiency virus. Oncologist 1999; 4: 309-17.
41. Kingma DW, Weiss A, Sorbara L, et al. Is lymphocytic interstitial pneumonitis an early stage of MALT lymphoma in HIV-infected pediatric patients? J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: A54 (abstr).
42. Granovsky MO, Mueller BU, Nicholson HS, et al. Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute. J Clin Oncol 1998; 16: 1729-35.
43. Biggar RJ, Frisch M, Goedert JJ. Risk of cancer in children with AIDS. JAMA 2000; 284: 205-09.
44. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA 1996; 276: 146-54.
45. Carpenter CC, Cooper DA, Fischl MA et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 2000; 283: 381-90.
46. Moore RD, Chiasson RE. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999; 13: 1933-42.
47. Jacobson LP, Yamashita TE, Detels R, et al. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. J Acquir Immune Defic Syndr 1999; 21 (suppl 1): S34-41.
48. Jones JL, Hanson DL, Dworkin MS, et al. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. J Acquir Immune Defic Syndr 1999; 21 (suppl 1): S11-17.
49. Selik R, Byers RH, Dworkin MS. Trends in diseases reported on US death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002; 29: 378-87.
50. Parkin DM, Wabinga H, Nambooze s, Wabwire-Mangen F. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS 1999; 13: 2563-70.
51. Wabinga HR, Parkin DM, Wabwire-Mangen F, Kugerwa JW. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer 1993; 54: 26-36.
52. Chokunonga E, Levy LM, Bassett MT, et al. Aids and cancer in Africa: the evolving epidemic in Zimbabwe. AIDS 1999; 13: 2583-88.
53. Newton R, Ziegler J, Beral V, et al. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 2001; 92: 622-27.
54. Newton R, Grulich A, Beral V, et al. Cancer and HIV infection in Rwanda. Lancet 1995; 1: 1378.
55. Newton R, Ngilimana P-J, Grulich A, et al. Cancer in Rwanda. Int J Cancer 1996; 66: 75-81.
56. Sitas F, Pacella-Norman R, Carrara H, et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 2000; 88: 489-92.
57. Sitas F, Bezwoda WR, Levin V, et al. Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. Br J Cancer 1997; 75: 1704-07.
58. Lucas SB, Diomande M, Hounnou A, et al. HIV-associated lymphoma in Africa: an autopsy study in Côte d'lvoire. Int J Cancer 1994; 59: 20-24.
59. Morgan D, Mahe C, Mayanja B, et al. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16: 597-603.
60. Mueller NE. Hodgkin's disease. In: Schottenfeld D, Fraumeni JF Jr (Eds). Cancer epidemiology and prevention, 2nd edn. New York: Oxford University Press, 1996: 893-919.
61. Vilchez RA, Madden CR, Kozinetz CA et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 817-23.
62. Grulich AE, Wan S, Law MG, et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 2000; 14: 133-40.
63. Knowles DM, Pirog ED. Pathology of AIDS-related lymphomas and other AIDS-defining neoplasms. Eur J Cancer 2001; 37: 1236-50.
64. Biggar RJ, Horm J, Goedert JJ, Melbye M. Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol 1987; 126: 578-86.
65. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, vol VII, number 143, Lyon: IARC Press 1997.
66. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from non-Hodgkin's lymphoma. Leuk Res 2002; 26: 903-08.
67. Thomas JO. Acquired immunodeficiency syndrome-associated cancer in Sub-Saharan Africa. Semin Oncol 2001; 28: 198-206.
68. Otieno MW, Remick SC, Whalen C. Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya. Int J Cancer 2001; 92: 687-91.
69. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001; 98: 3406-12.
70. Sparano JA. Clinical aspects and management of AIDS-related lymphoma. Eur J Cancer 2001; 37: 1296-305.
71. Vaccher E, Spina M, Tirelli U. Clinical aspects and management Hodgkin's disease and other tumours in HIV-infected individuals. Eur J Cancer 2001; 37: 1306-15.
72. Conti S, Masocco M, Pezzotti P, et al. Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses. J Acquir Immune Defic Syndr 2000; 25: 451-58.
73. Lederberger B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet 1999; 353: 863-68.